Glowing drug lights up brain tumors for surgeons
NCT ID NCT07210632
Summary
This early study aims to see if a cancer drug (nivolumab) can be made to glow with a special dye, allowing doctors to see exactly where it goes in the brain during surgery for aggressive tumors called high-grade gliomas. The main goals are to check if this glowing version of the drug is safe and to find the right dose that makes the tumor light up clearly under a microscope. It's for adults who are already scheduled for brain tumor surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.